首页> 美国政府科技报告 >Phase I/II Trial of Epothilone Analog BMS-247550, Mitoxantrone, and Prednisone in HRPC Patients Previously Treated with Chemotherapy
【24h】

Phase I/II Trial of Epothilone Analog BMS-247550, Mitoxantrone, and Prednisone in HRPC Patients Previously Treated with Chemotherapy

机译:埃博霉素类似物Bms-247550,米托蒽醌和泼尼松用于化疗前HRpC患者的I / II期试验

获取原文

摘要

This grant report includes a summary of the accomplishment of the statement of work, in addition to the complete protocol, consent, and Contracts and Grants office confirmation of submission of a grant to support the clinical trial. The clinical trial covered by this grant has been activated and is accruing patients.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号